Diagen Biyoteknolojik Sistemler

Name

Diagen Biyoteknolojik Sistemler

Legal name

Diagen İnsan Sağlığı

Website

https://diagen.com.tr

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Ankara

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Diagnostic Test Kits: Sale of rapid test kits and molecular diagnostic kits for human health applications
2. Laboratory Services: Analysis services including microbiota analysis, PCR analysis, sequencing, nucleic acid extraction, and ELISA testing
3. Laboratory Setup Consulting: Turnkey laboratory installation solutions and consulting services for healthcare facilities

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Diagen Biyoteknolojik Sistemler manufactures and sells rapid diagnostic test kits (including a flagship IVDR-certified multi-pathogen respiratory antigen kit for SARS-CoV-2, Flu A/B, RSV, and ADV) and molecular diagnostic kits for human health applications. The company also operates a laboratory services arm providing PCR, sequencing, nucleic acid extraction, ELISA, and microbiota analyses, and offers turnkey laboratory setup consulting for healthcare facilities and veterinary diagnostics providers in Turkey.

Product overview

Diagen Biyoteknolojik Sistemler offers a portfolio of human health diagnostic products and laboratory services. The core offerings include rapid test kits (Hızlı Test Kitleri) and molecular diagnostic kits (Moleküler Tanı Kitleri), which form the primary product lines. These are complemented by a suite of laboratory analysis services including Microbiota Analyses (Mikrobiyota Analizleri), PCR Analyses (PCR Analizleri), Sequencing Service & Design (Sekans Hizmeti & Tasarım), Nucleic Acid Extraction Analyses (Nükleik Asit Ekstraksiyon Analizleri), and ELISA Analyses. The company also provides laboratory setup consulting services (Laboratuvar Kurulumu). The flagship rapid test product is the Hızlı Kit line which includes the Çoklu Solunum Yolu Antijen Kiti for multi-pathogen respiratory screening.

Differentiator

Problem solved

Functional benefit

Brands

• Diagen İnsan Sağlığı: Human health division offering diagnostic test kits and laboratory solutions

Products and services

• Çoklu Solunum Yolu Antijen Kiti (Multi Respiratory Pathogen Antigen Kit) Rapid antigen test kit for simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, RSV, and Adenovirus (ADV) from respiratory samples, providing results in 10-15 minutes with high sensitivity. IVDR-certified for trust, sensitivity, and reliability.
• Hızlı Test Kitleri (Rapid Test Kits) Rapid diagnostic test kits for point-of-care human health testing, providing quick and reliable results for various pathogens.
• Moleküler Tanı Kitleri (Molecular Diagnostic Kits) Molecular diagnostic kits for laboratory-based detection and identification of pathogens using nucleic acid analysis techniques.
• Mikrobiyota Analizleri (Microbiota Analyses) Laboratory analysis service for studying and characterizing microbial communities in human samples.
• PCR Analizleri (PCR Analyses) Polymerase Chain Reaction analysis services for amplification and detection of specific DNA sequences for diagnostic purposes.
• Sekans Hizmeti & Tasarım (Sequencing Service & Design) DNA and RNA sequencing services including custom assay design for research and diagnostic applications.
• Nükleik Asit Ekstraksiyon Analizleri (Nucleic Acid Extraction Analyses) Extraction and purification services for isolating nucleic acids from biological samples for downstream analysis.
• ELISA Analizleri (ELISA Analyses) Enzyme-Linked Immunosorbent Assay services for detecting and quantifying antigens or antibodies in clinical samples.
• Laboratuvar Kurulumu (Laboratory Setup) Comprehensive laboratory setup consulting and turnkey solutions for establishing diagnostic testing facilities.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• Cepheid (Danaher): Developer of the GeneXpert molecular diagnostic system with widely adopted Xpert respiratory panels (SARS-CoV-2, Flu, RSV). Comparable to Diagen in molecular respiratory pathogen testing and PCR-based diagnostics.
• Roche Diagnostics: Global IVD incumbent with extensive respiratory, infectious disease, and molecular diagnostics portfolios (cobas, Liat, Elecsys). Competes with Diagen in hospital laboratories in Turkey and across respiratory/molecular testing workflows.
• bioMérieux: Global IVD leader in microbiology and infectious disease diagnostics, offering culture, immunoassays, and molecular panels (e.g., BioFire syndromic panels). Comparable to Diagen in microbiology/infectious disease focus and overlapping respiratory pathogen testing capabilities.
• Abbott Diagnostics: Global diagnostics leader with rapid antigen (Binax), molecular (Alinity m, ID NOW), and immunoassay platforms covering respiratory pathogens. Comparable as a broad incumbent in the same hospital procurement decisions Diagen targets.
• Hologic: U.S. diagnostics company with Panther molecular systems and a respiratory pathogen test menu (e.g., Panther Fusion). Comparable to Diagen in molecular infectious disease testing sold to hospital labs.

Regional players

• A1 Life Sciences: Emerging Turkish biotech/IVD company offering diagnostic kits and molecular testing services in Turkey. Comparable regional peer to Diagen in respiratory/molecular diagnostics and Turkish lab services.
• RTA Laboratories: Turkish IVD and medical device distributor/manufacturer serving clinical laboratories with diagnostic kits and equipment in Turkey. Direct regional competitor to Diagen in the Turkish B2B diagnostic kit and laboratory services market.

Direct peers

• SD Biosensor: South Korean IVD manufacturer specializing in rapid antigen test kits (including multi-pathogen respiratory panels) and molecular diagnostics sold internationally. Highly comparable to Diagen in product mix (rapid + molecular kits, lab services) and scale profile as a regional IVD specialist.
• Meridian Bioscience: U.S. diagnostics company focused on gastrointestinal and respiratory molecular and immunoassay kits, now part of Revvity/Sumitomo's life sciences portfolio. Comparable to Diagen in infectious disease molecular kit focus and small-to-mid IVD player profile.
• QuidelOrtho (Quidel + Ortho Clinical Diagnostics): U.S.-based diagnostics company with a flagship rapid antigen portfolio (e.g., Sofia SARS/FLU/RSV) plus a broader clinical chemistry and immunoassay menu. Directly comparable to Diagen in rapid respiratory antigen kit positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diagen Biyoteknolojik Sistemler